Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | EVCM | GENI |
|---|---|---|
| Price | $9.07 | $5.99 |
| Change today | ▲ 1.45% | ▼ 0.50% |
| Market cap | $1.60B | $1.60B |
| Return, 3 months | -9.9% | -7.4% |
| Return, year to date | -25.1% | -45.6% |
| Return, 1 year | -20.4% | -49.2% |
| P/E (TTM) | 47.7 | -8.9 |
| P/B | 2.2 | 2.3 |
| P/E percentile vs own 5y | 82nd | 56th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +23.2% | +74.5% |
| Analyst buy share | 50% | 85% |
| RSI (14) | 55 | 42 |
| 30-day volatility | 96.8% | 74.6% |
| Max drawdown, 1 year | -52.9% | -70.8% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
